FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Oleh Hornykiewicz

Research Profile

Chemicals & Drugs

Disorders

Parkinson's Disease

Anatomy

Physiology

Brain Chemistry

Living Beings

Rats

Co-author Network

Publications

TOP 3
Christian Pifl; Rebeca Adánez; Javier Blesa; Carmen Cavada; Oleh Hornykiewicz; José A Obeso
Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: relation to severity of Parkinsonism.
Christian Pifl; Stephen J Kish; Oleh Hornykiewicz
Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms.
Bazoumana Ouattara; Alex Rajput; Ali H Rajput; Ivo Vranesic; Fabrizio Gasparini; Baltazar Gomez-Mancilla; Laurent Grégoire; Oleh Hornykiewicz; Donald R Johns; Marc Morissette; Graeme Bilbe; Thérèse Di Paolo
Metabotropic glutamate receptor type 5 in levodopa-induced motor complications.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Oleh Hornykiewicz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Christian Pifl; Rebeca Adánez; Javier Blesa; Carmen Cavada; Oleh Hornykiewicz; José A Obeso
Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: relation to severity of Parkinsonism.
Journal of neurochemistry 2013;125(5):657-62.
2012: Christian Pifl; Stephen J Kish; Oleh Hornykiewicz
Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms.
Movement disorders : official journal of the Movement Disorder Society 2012;27(13):1618-24.
2011: Bazoumana Ouattara; Alex Rajput; Ali H Rajput; Ivo Vranesic; Fabrizio Gasparini; Baltazar Gomez-Mancilla; Laurent Grégoire; Oleh Hornykiewicz; Donald R Johns; Marc Morissette; Graeme Bilbe; Thérèse Di Paolo
Metabotropic glutamate receptor type 5 in levodopa-induced motor complications.
Neurobiology of aging 2011;32(7):1286-95.
2011: T M Peneder; Petra Scholze; Michael L Berger; Harald Reither; G Heinze; J Bertl; J Bauer; E K Richfield; Oleh Hornykiewicz; Christian Pifl
Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice.
Neuroscience 2011;180():280-92.
2011: Junchao Tong; Yoshiaki Furukawa; Allan Sherwin; Oleh Hornykiewicz; Stephen J Kish
Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain.
Neurobiology of disease 2011;41(2):458-68.
2010: Oleh Hornykiewicz
A brief history of levodopa.
Journal of neurology 2010;257(Suppl 2):S249-52.
2010: Junchao Tong; Henry Wong; Mark Guttman; Lee C Ang; Lysia S Forno; Mitsunobu Shimadzu; Ali H Rajput; Manfred D Muenter; Stephen J Kish; Oleh Hornykiewicz; Yoshiaki Furukawa
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Brain : a journal of neurology 2010;133(Pt 1):172-88.
2009: Isabelle Boileau; Mark Guttman; Pablo Rusjan; John R Adams; Sylvain Houle; Junchao Tong; Oleh Hornykiewicz; Yoshiaki Furukawa; Alan Wilson; Shitij Kapur; Stephen J Kish
Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
Brain : a journal of neurology 2009;132(Pt 5):1366-75.
2009: Pershia Samadi; Alex Rajput; Frederic Calon; Laurent Grégoire; Oleh Hornykiewicz; Ali H Rajput; Thérèse Di Paolo
Metabotropic glutamate receptor II in the brains of Parkinsonian patients.
Journal of neuropathology and experimental neurology 2009;68(4):374-82.
2008: Ali H Rajput; H H Sitte; Alex Rajput; Mark E Fenton; Christian Pifl; Oleh Hornykiewicz
Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation.
Neurology 2008;70(16 Pt 2):1403-10.
2008: Oleh Hornykiewicz
Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.
Neuro-degenerative diseases 2008;5(3-4):114-7.
2008: Stephen J Kish; Junchao Tong; Oleh Hornykiewicz; Ali H Rajput; Li-Jan Chang; Mark Guttman; Yoshiaki Furukawa
Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
Brain : a journal of neurology 2008;131(Pt 1):120-31.
2007: Junchao Tong; Oleh Hornykiewicz; Yoshiaki Furukawa; Stephen J Kish
Marked dissociation between high noradrenaline versus low noradrenaline transporter levels in human nucleus accumbens.
Journal of neurochemistry 2007;102(5):1691-702.
2006: Junchao Tong; Oleh Hornykiewicz; Stephen J Kish
Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline.
Archives of neurology 2006;63(12):1724-8.
2006: Christian Pifl; Oleh Hornykiewicz
Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys.
Neurochemistry international 2006;49(5):519-24.
2006: Oleh Hornykiewicz
The discovery of dopamine deficiency in the parkinsonian brain.
Journal of neural transmission. Supplementum 2006;(70):9-15.
2006: Junchao Tong; Oleh Hornykiewicz; Stephen J Kish
Identification of a noradrenaline-rich subdivision of the human nucleus accumbens.
Journal of neurochemistry 2006;96(2):349-54.
2005: Irina Woldman; Harald Reither; Alexandra Kattinger; Oleh Hornykiewicz; Christian Pifl
Dopamine inhibits cell growth and cell cycle by blocking ribonucleotide reductase.
Neuropharmacology 2005;48(4):525-37.
2004: C Warren Olanow; Yves Agid; Yoshikuni Mizuno; Alberto Albanese; Ubaldo Bonuccelli; U Bonucelli; Philippe Damier; Justo De Yebenes; Oscar S Gershanik; Mark Guttman; Francisco Grandas; Mark Hallett; Oleh Hornykiewicz; Peter Jenner; Regina Katzenschlager; William J Langston; Peter LeWitt; Eldad Melamed; M A Mena; Patrick P Michel; Catherine Mytilineou; Jose A Obeso; Werner Poewe; Niall Quinn; Rita Raisman-Vozari; Ali H Rajput; Olivier Rascol; Cristina Sampaio; Fabrizio Stocchi
Levodopa in the treatment of Parkinson's disease: current controversies.
Movement disorders : official journal of the Movement Disorder Society 2004;19(9):997-1005.
2004: Kenichi Yamamoto; Oleh Hornykiewicz
Proposal for a noradrenaline hypothesis of schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 2004;28(5):913-22.
2004: Luigi Zecca; Antonella Stroppolo; Alberto Gatti; Davide Tampellini; Marco Toscani; Mario Gallorini; Giuseppe Giaveri; paolo arosio; Paolo Santambrogio; Ruggero G Fariello; Erdem Karatekin; Mark H Kleinman; Nicholas J Turro; Oleh Hornykiewicz; Fabio A Zucca
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(26):9843-8.
2004: Ali H Rajput; Mark E Fenton; Thérèse Di Paolo; Harold Sitte; Christian Pifl; Oleh Hornykiewicz
Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off.
Parkinsonism & related disorders 2004;10(4):221-6.
2004: Frederic Calon; Mehdi Dridi; Oleh Hornykiewicz; Paul J Bédard; Ali H Rajput; Thérèse Di Paolo
Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.
Brain : a journal of neurology 2004;127(Pt 5):1075-84.
2004: Christian Pifl; Maya Khorchide; Alexandra Kattinger; Harald Reither; John Hardy; Oleh Hornykiewicz
alpha-Synuclein selectively increases manganese-induced viability loss in SK-N-MC neuroblastoma cells expressing the human dopamine transporter.
Neuroscience letters 2004;354(1):34-7.
2003: Frederic Calon; Ali H Rajput; Oleh Hornykiewicz; Paul J Bédard; Thérèse Di Paolo
Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
Neurobiology of disease 2003;14(3):404-16.
2003: John W Haycock; Laurence Becker; Lee Ang; Yoshiaki Furukawa; Oleh Hornykiewicz; Stephen J Kish
Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum.
Journal of neurochemistry 2003;87(3):574-85.
2003: Frederic Calon; Marc Morissette; Ali H Rajput; Oleh Hornykiewicz; Paul J Bédard; Thérèse Di Paolo
Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications.
Movement disorders : official journal of the Movement Disorder Society 2003;18(3):241-53.
2002: Christian Pifl; Alexandra Kattinger; Harald Reither; Oleh Hornykiewicz
Cellular effects of dopamine--beyond oxidative mechanisms.
Parkinsonism & related disorders 2002;8(6):433-7.
2002: Oleh Hornykiewicz
Dopamine miracle: from brain homogenate to dopamine replacement.
Movement disorders : official journal of the Movement Disorder Society 2002;17(3):501-8.
2002: Ali H Rajput; Mark E Fenton; Sam Birdi; Rob Macaulay; David George; Bohdar Rozdilsky; Lee C Ang; Ambikaipakan Senthilselvan; Oleh Hornykiewicz
Clinical-pathological study of levodopa complications.
Movement disorders : official journal of the Movement Disorder Society 2002;17(2):289-96.
2002: Frederic Calon; Sam Birdi; Ali H Rajput; Oleh Hornykiewicz; Paul J Bédard; Thérèse Di Paolo
Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias.
Journal of neuropathology and experimental neurology 2002;61(2):186-96.
2002: Oleh Hornykiewicz
L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent.
Amino acids 2002;23(1-3):65-70.
2001: W Birkmayer; Oleh Hornykiewicz
The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961.
Wiener klinische Wochenschrift 2001;113(22):851-4.
2001: Oleh Hornykiewicz
How L-DOPA was discovered as a drug for Parkinson's disease 40 years ago.
Wiener klinische Wochenschrift 2001;113(22):855-62.
2001: P K Tekumalla; Frederic Calon; Zia Rahman; Sam Birdi; Ali H Rajput; Oleh Hornykiewicz; Thérèse Di Paolo; Paul J Bédard; Eric J Nestler
Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease.
Biological psychiatry 2001;50(10):813-6.
2001: Oleh Hornykiewicz
Chemical neuroanatomy of the basal ganglia--normal and in Parkinson's disease.
Journal of chemical neuroanatomy 2001;22(1-2):3-12.
2001: Christian Pifl; J Zezula; Andreas Spittler; Alexandra Kattinger; Harald Reither; Marc G Caron; Oleh Hornykiewicz
Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(9):1607-9.
2001: Oleh Hornykiewicz
Dopamine and Parkinson's disease. A personal view of the past, the present, and the future.
Advances in neurology 2001;86():1-11.
2000: Yoshiaki Furukawa; Oleh Hornykiewicz; Stanley Fahn; Stephen J Kish
Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation.
Neurology 2000;54(5):1193-5.
1999: Yoshiaki Furukawa; T G Nygaard; M Gütlich; Ali H Rajput; Christian Pifl; L DiStefano; Li-Jan Chang; K Price; M Shimadzu; Oleh Hornykiewicz; John W Haycock; Stephen J Kish
Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia.
Neurology 1999;53(5):1032-41.
1998: W Birkmayer; Oleh Hornykiewicz
The effect of l-3,4-dihydroxyphenylalanine (=DOPA) on akinesia in parkinsonism.
Parkinsonism & related disorders 1998;4(2):59-60.
1998: H Ehringer; Oleh Hornykiewicz
Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system.
Parkinsonism & related disorders 1998;4(2):53-7.
1998: Oleh Hornykiewicz
Biochemical aspects of Parkinson's disease.
Neurology 1998;51(2 Suppl 2):S2-9.
1998: MD Muenter; L S Forno; Oleh Hornykiewicz; Stephen J Kish; Demetrius M Maraganore; Richard Caselli; H Okazaki; F M Howard; BJ Snow; Donald B Calne
Hereditary form of parkinsonism--dementia.
Annals of neurology 1998;43(6):768-81.
1998: Yoshiaki Furukawa; Anthony E Lang; JM Trugman; Thomas D Bird; A Hunter; M Sadeh; T Tagawa; Peter St George-Hyslop; Mark Guttman; L W Morris; Oleh Hornykiewicz; M Shimadzu; Stephen J Kish
Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia.
Neurology 1998;50(4):1015-20.
1998: Yoshiaki Furukawa; M Shimadzu; Oleh Hornykiewicz; Stephen J Kish
Molecular and biochemical aspects of hereditary progressive and dopa-responsive dystonia.
Advances in neurology 1998;78():267-82.
1996: J M Wilson; Allan Levey; Alex Rajput; Lee Ang; Mark Guttman; K Shannak; Hyman B Niznik; Oleh Hornykiewicz; C Pifl; Stephen J Kish
Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease.
Neurology 1996;47(3):718-26.
1996: Christian Pifl; Oleh Hornykiewicz; Bruno GIROS; Marc G Caron
Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter.
The Journal of pharmacology and experimental therapeutics 1996;277(3):1437-43.
1996: Yoshiaki Furukawa; M Shimadzu; Ali H Rajput; Y Shimizu; T Tagawa; Hideo Mori; Masayuki Yokochi; H Narabayashi; Oleh Hornykiewicz; Yoshikuni Mizuno; Stephen J Kish
GTP-cyclohydrolase I gene mutations in hereditary progressive amd dopa-responsive dystonia.
Annals of neurology 1996;39(5):609-17.
1995: Stephen J Kish; X H Zhong; Oleh Hornykiewicz; J W Haycock
Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies?
Annals of neurology 1995;38(2):260-4.
1995: Christian Pifl; Helmut Drobny; Harald Reither; Oleh Hornykiewicz; Ernst A Singer
Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
Molecular pharmacology 1995;47(2):368-73.
1995: X H Zhong; J W Haycock; K Shannak; Yvonne Robitaille; J Fratkin; A H Koeppen; Oleh Hornykiewicz; Stephen J Kish
Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy.
Movement disorders : official journal of the Movement Disorder Society 1995;10(1):10-7.
1994: Halina BARAN; K Vass; H Lassmann; Oleh Hornykiewicz
The cyclooxygenase and lipoxygenase inhibitor BW755C protects rats against kainic acid-induced seizures and neurotoxicity.
Brain research 1994;646(2):201-6.
1994: Ali H Rajput; W R Gibb; X H Zhong; K S Shannak; Stephen J Kish; L G Chang; Oleh Hornykiewicz
Dopa-responsive dystonia: pathological and biochemical observations in a case.
Annals of neurology 1994;35(4):396-402.
1994: K Shannak; Alex Rajput; B Rozdilsky; Stephen J Kish; J Gilbert; Oleh Hornykiewicz
Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects.
Brain research 1994;639(1):33-41.
1994: Oleh Hornykiewicz; K Shannak
Brain monoamines in progressive supranuclear palsy--comparison with idiopathic Parkinson's disease.
Journal of neural transmission. Supplementum 1994;42():219-27.
1993: L Trevor Young; Peter P Li; Stephen J Kish; K P Siu; A Kamble; Oleh Hornykiewicz; Jerry J Warsh
Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder.
Journal of neurochemistry 1993;61(3):890-8.
1993: H Hörtnagl; M L Berger; L Havelec; Oleh Hornykiewicz
Role of glucocorticoids in the cholinergic degeneration in rat hippocampus induced by ethylcholine aziridinium (AF64A).
The Journal of neuroscience : the official journal of the Society for Neuroscience 1993;13(7):2939-45.
1993: Oleh Hornykiewicz
Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms.
Advances in neurology 1993;60():140-7.
1992: Christian Pifl; Christian Nanoff; G Schingnitz; W Schütz; Oleh Hornykiewicz
Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease.
Journal of neurochemistry 1992;58(6):1997-2004.
1992: M L Berger; Mario Veitl; S Malessa; E Sluga; Oleh Hornykiewicz
Cholinergic markers in ALS spinal cord.
Journal of the neurological sciences 1992;108(1):114-7.
1992: Christian Pifl; G Schingnitz; Oleh Hornykiewicz
Striatal and non-striatal neurotransmitter changes in MPTP-parkinsonism in rhesus monkey: the symptomatic versus the asymptomatic condition.
Neurochemistry international 1992;20 Suppl():295S-297S.
1992: Christian Pifl; Harald Reither; Oleh Hornykiewicz
Functional sensitization of striatal dopamine D1 receptors in the 6-hydroxydopamine-lesioned rat.
Brain research 1992;572(1-2):87-93.
1992: Stephen J Kish; K Shannak; Alex Rajput; J H Deck; Oleh Hornykiewicz
Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease.
Journal of neurochemistry 1992;58(2):642-8.
1992: Stephen J Kish; M Mamelak; C Slimovitch; L M Dixon; A Lewis; K Shannak; L DiStefano; Li-Jan Chang; Oleh Hornykiewicz
Brain neurotransmitter changes in human narcolepsy.
Neurology 1992;42(1):229-34.
1992: Oleh Hornykiewicz
Mechanisms of neuronal loss in Parkinson's disease: a neuroanatomical-biochemical perspective.
Clinical neurology and neurosurgery 1992;94 Suppl():S9-11.
1991: O Bertel; S Malessa; E Sluga; Oleh Hornykiewicz
Amyotrophic lateral sclerosis: changes of noradrenergic and serotonergic transmitter systems in the spinal cord.
Brain research 1991;566(1-2):54-60.
1991: S Malessa; P N Leigh; O Bertel; E Sluga; Oleh Hornykiewicz
Amyotrophic lateral sclerosis: glutamate dehydrogenase and transmitter amino acids in the spinal cord.
Journal of neurology, neurosurgery, and psychiatry 1991;54(11):984-8.
1991: Christian Pifl; Harald Reither; Oleh Hornykiewicz
Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum.
European journal of pharmacology 1991;202(2):273-6.
1991: E Suess; S Malessa; Karl Ungersböck; P Kitz; Ivo Podreka; Karl Heimberger; Oleh Hornykiewicz; Lüder Deecke
Technetium-99m-d,1-hexamethylpropyleneamine oxime (HMPAO) uptake and glutathione content in brain tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(9):1675-81.
1991: L Trevor Young; Jerry J Warsh; Peter P Li; K P Siu; L Becker; J Gilbert; Oleh Hornykiewicz; Stephen J Kish
Maturational and aging effects on guanine nucleotide binding protein immunoreactivity in human brain.
Brain research. Developmental brain research 1991;61(2):243-8.
1991: H Hörtnagl; M L Berger; Harald Reither; Oleh Hornykiewicz
Cholinergic deficit induced by ethylcholine aziridinium (AF64A) in rat hippocampus: effect on glutamatergic systems.
Naunyn-Schmiedeberg's archives of pharmacology 1991;344(2):213-9.
1991: Jerry J Warsh; J M Politsky; Peter P Li; Stephen J Kish; Oleh Hornykiewicz
Reduced striatal [3H]inositol 1,4,5-trisphosphate binding in Huntington's disease.
Journal of neurochemistry 1991;56(4):1417-22.
1991: Stephen J Kish; F Du; D A Parks; Yvonne Robitaille; Melvyn Ball; L Schut; Oleh Hornykiewicz; Robert Schwarcz
Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophy.
Annals of neurology 1991;29(1):100-4.
1991: Christian Pifl; G Schingnitz; Oleh Hornykiewicz
Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey.
Neuroscience 1991;44(3):591-605.
1990: Stephen J Kish; R Kleinert; M Minauf; J Gilbert; G F Walter; C Slimovitch; E Maurer; Y Rezvani; R Myers; Oleh Hornykiewicz
Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome.
The American journal of psychiatry 1990;147(10):1358-63.
1990: Stephen J Kish; L DiStefano; S Dozic; Yvonne Robitaille; Alex Rajput; J H Deck; Oleh Hornykiewicz
[3H]vesamicol binding in human brain cholinergic deficiency disorders.
Neuroscience letters 1990;117(3):347-52.
1990: D E Riley; Anthony E Lang; A Lewis; L Resch; P Ashby; Oleh Hornykiewicz; S Black
Cortical-basal ganglionic degeneration.
Neurology 1990;40(8):1203-12.
1990: Christian Pifl; O Bertel; G Schingnitz; Oleh Hornykiewicz
Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Neurochemistry international 1990;17(2):263-70.
1990: F Seitelberger; H Lassmann; Oleh Hornykiewicz
Some mechanisms of brain edema studied in a kainic acid model.
Acta neurobiologiae experimentalis 1990;50(4-5):263-7.
1989: Halina BARAN; H Hörtnagl; Oleh Hornykiewicz
Kainic acid-induced seizures: potentiation by alpha-methyl-p-tyrosine.
Brain research 1989;495(2):253-60.
1989: M L Berger; H Lassmann; Oleh Hornykiewicz
Limbic seizures without brain damage after injection of low doses of kainic acid into the amygdala of freely moving rats.
Brain research 1989;489(2):261-72.
1989: Stephen J Kish; H Karlinsky; L Becker; J Gilbert; M Rebbetoy; Li-Jan Chang; L DiStefano; Oleh Hornykiewicz
Down's syndrome individuals begin life with normal levels of brain cholinergic markers.
Journal of neurochemistry 1989;52(4):1183-7.
1989: Oleh Hornykiewicz
Ageing and neurotoxins as causative factors in idiopathic Parkinson's disease--a critical analysis of the neurochemical evidence.
Progress in neuro-psychopharmacology & biological psychiatry 1989;13(3-4):319-28.
1988: J J Gilbert; Stephen J Kish; Li-Jan Chang; C Morito; K Shannak; Oleh Hornykiewicz
Dementia, parkinsonism, and motor neuron disease: neurochemical and neuropathological correlates.
Annals of neurology 1988;24(5):688-91.
1988: Christian Pifl; G Schingnitz; Oleh Hornykiewicz
The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease.
Neuroscience letters 1988;92(2):228-33.
1988: Oleh Hornykiewicz
The pathochemical perspectives of Parkinson's disease. An attempt at a neurochemical definition.
Functional neurology 1988;3(4):379-91.
1988: Christian Pifl; L Pichler; W Kobinger; Oleh Hornykiewicz
The dopamine autoreceptor agonist, B-HT 920, preferentially reduces brain dopamine release in vivo: biochemical indices of brain dopamine, noradrenaline and serotonin in ventriculocisternal perfusates in the cat.
European journal of pharmacology 1988;153(1):33-44.
1988: Stephen J Kish; K Shannak; Oleh Hornykiewicz
Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.
The New England journal of medicine 1988;318(14):876-80.
1988: Christian Pifl; Oleh Hornykiewicz
Postsynaptic dopamine agonist properties of B-HT 920 as revealed by concomitant D-1 receptor stimulation.
European journal of pharmacology 1988;146(1):189-91.
1988: Oleh Hornykiewicz
Neurochemical pathology and the etiology of Parkinson's disease: basic facts and hypothetical possibilities.
The Mount Sinai journal of medicine, New York 1988;55(1):11-20.
1988: Henry N Wagner; Daniel R Weinberger; J E Kleinman; M F Casanova; C J Gibbs; R E Gur; Oleh Hornykiewicz; Michael J Kuhar; J W Pettegrew; Philip Seeman
Neuroimaging and neuropathology.
Schizophrenia bulletin 1988;14(3):383-97.
1988: Oleh Hornykiewicz; Stephen J Kish; L E Becker; I Farley; K Shannak
Biochemical evidence for brain neurotransmitter changes in idiopathic torsion dystonia (dystonia musculorum deformans).
Advances in neurology 1988;50():157-65.
1987: Stephen J Kish; K Shannak; Oleh Hornykiewicz
Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum.
Annals of neurology 1987;22(3):386-9.
1987: Halina BARAN; H Lassmann; G Sperk; F Seitelberger; Oleh Hornykiewicz
Effect of mannitol treatment on brain neurotransmitter markers in kainic acid-induced epilepsy.
Neuroscience 1987;21(3):679-84.
1987: L Pichler; Christian Pifl; Oleh Hornykiewicz; W Kobinger
The dopamine autoreceptor agonist B-HT 920 inhibits in vivo dopamine release into the cerebroventricular system of cats.
European journal of pharmacology 1987;135(2):239-42.
1987: Stephen J Kish; Alex Rajput; J Gilbert; B Rozdilsky; Li-Jan Chang; K Shannak; Oleh Hornykiewicz
GABA-dopamine relationship in Parkinson's disease striatum.
Advances in neurology 1987;45():75-7.
1987: Oleh Hornykiewicz; Stephen J Kish
Biochemical pathophysiology of Parkinson's disease.
Advances in neurology 1987;45():19-34.
1986: D Hinzen; Oleh Hornykiewicz; W Kobinger; L Pichler; Christian Pifl; G Schingnitz
The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment.
European journal of pharmacology 1986;131(1):75-86.
1986: Oleh Hornykiewicz; Stephen J Kish; L E Becker; I Farley; K Shannak
Brain neurotransmitters in dystonia musculorum deformans.
The New England journal of medicine 1986;315(6):347-53.
1986: B R Seizinger; D C Liebisch; Stephen J Kish; R M Arendt; Oleh Hornykiewicz; A Herz
Opioid peptides in Huntington's disease: alterations in prodynorphin and proenkephalin system.
Brain research 1986;378(2):405-8.
1986: Stephen J Kish; Alex Rajput; J Gilbert; B Rozdilsky; Li-Jan Chang; K Shannak; Oleh Hornykiewicz
Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss.
Annals of neurology 1986;20(1):26-31.
1986: Stephen J Kish; C L Morito; Oleh Hornykiewicz
Brain glutathione peroxidase in neurodegenerative disorders.
Neurochemical pathology 1986;4(1):23-8.
1986: H Lassmann; Halina BARAN; U Petsche; K Kitz; G Sperk; Oleh Hornykiewicz; F Seitelberger
Ultrastructural analysis of rat brain tissue following systemic kainate administration.
Advances in experimental medicine and biology 1986;203():223-30.
1986: Oleh Hornykiewicz
Brain noradrenaline and schizophrenia.
Progress in brain research 1986;65():29-39.
1985: Stephen J Kish; Li-Jan Chang; L Mirchandani; K Shannak; Oleh Hornykiewicz
Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers.
Annals of neurology 1985;18(5):530-6.
1985: Stephen J Kish; C Morito; Oleh Hornykiewicz
Glutathione peroxidase activity in Parkinson's disease brain.
Neuroscience letters 1985;58(3):343-6.
1985: Stephen J Kish; T L Perry; V P Sweeney; Oleh Hornykiewicz
Brain gamma-aminobutyric acid and benzodiazepine receptor binding in dialysis encephalopathy.
Neuroscience letters 1985;58(2):241-4.
1985: Halina BARAN; G Sperk; H Hörtnagl; G Sapetschnig; Oleh Hornykiewicz
Alpha 2-adrenoceptors modulate kainic acid-induced limbic seizures.
European journal of pharmacology 1985;113(2):263-9.
1985: G Sperk; H Lassmann; Halina BARAN; F Seitelberger; Oleh Hornykiewicz
Kainic acid-induced seizures: dose-relationship of behavioural, neurochemical and histopathological changes.
Brain research 1985;338(2):289-95.
1985: Stephen J Kish; I H Fox; B M Kapur; K Lloyd; Oleh Hornykiewicz
Brain benzodiazepine receptor binding and purine concentration in Lesch-Nyhan syndrome.
Brain research 1985;336(1):117-23.
1985: Oleh Hornykiewicz
[The life history of brain dopamine].
Wiener klinische Wochenschrift 1985;97(8):350-4.
1985: Stephen J Kish; J J Gilbert; Li-Jan Chang; L Mirchandani; K Shannak; Oleh Hornykiewicz
Brain neurotransmitter abnormalities in neuronal intranuclear inclusion body disorder.
Annals of neurology 1985;17(4):405-7.
1984: H Hörtnagl; L Pichler; U Holzer-Petsche; Oleh Hornykiewicz; W Kobinger
B-HT 958--an antagonist at alpha 2-adrenoceptors and an agonist at dopamine autoreceptors in the brain.
European journal of pharmacology 1984;106(2):335-44.
1984: H Lassmann; U Petsche; K Kitz; Halina BARAN; G Sperk; F Seitelberger; Oleh Hornykiewicz
The role of brain edema in epileptic brain damage induced by systemic kainic acid injection.
Neuroscience 1984;13(3):691-704.
1984: Stephen J Kish; K S Shannak; Ali H Rajput; J J Gilbert; Oleh Hornykiewicz
Cerebellar norepinephrine in patients with Parkinson's disease and control subjects.
Archives of neurology 1984;41(6):612-4.
1984: Stephen J Kish; K S Shannak; Oleh Hornykiewicz
Reduction of noradrenaline in cerebellum of patients with olivopontocerebellar atrophy.
Journal of neurochemistry 1984;42(5):1476-8.
1984: Stephen J Kish; T L Perry; Oleh Hornykiewicz
Benzodiazepine receptor binding in cerebellar cortex: observations in olivopontocerebellar atrophy.
Journal of neurochemistry 1984;42(2):466-9.
1984: Oleh Hornykiewicz; Stephen J Kish
Neurochemical basis of dementia in Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1984;11(1 Suppl):185-90.
1983: G Sperk; H Lassmann; Halina BARAN; Stephen J Kish; F Seitelberger; Oleh Hornykiewicz
Kainic acid induced seizures: neurochemical and histopathological changes.
Neuroscience 1983;10(4):1301-15.
1983: Stephen J Kish; G Sperk; Oleh Hornykiewicz
Alterations in benzodiazepine and GABA receptor binding in rat brain following systemic injection of kainic acid.
Neuropharmacology 1983;22(11):1303-9.
1983: Stephen J Kish; K S Shannak; T L Perry; Oleh Hornykiewicz
Neuronal [3H]benzodiazepine binding and levels of GABA, glutamate, and taurine are normal in Huntington's disease cerebellum.
Journal of neurochemistry 1983;41(5):1495-7.
1983: Stephen J Kish; T L Perry; Oleh Hornykiewicz
Increased GABA receptor binding in dominantly-inherited cerebellar ataxias.
Brain research 1983;269(2):370-3.
1983: H Hörtnagl; E Schlögl; G Sperk; Oleh Hornykiewicz
The topographical distribution of the monoaminergic innervation in the basal ganglia of the human brain.
Progress in brain research 1983;58():269-74.
1982: Oleh Hornykiewicz
Brain catecholamines in schizophrenia -- a good case for noradrenaline.
Nature 1982;299(5883):484-6.
1982: Ali H Rajput; B Rozdilsky; Oleh Hornykiewicz; K Shannak; T Lee; Philip Seeman
Reversible drug-induced parkinsonism. Clinicopathologic study of two cases.
Archives of neurology 1982;39(10):644-6.
1982: M Berger; G Sperk; Oleh Hornykiewicz
Serotonergic denervation partially protects rat striatum from kainic acid toxicity.
Nature 1982;299(5880):254-6.
1982: Oleh Hornykiewicz
Imbalance of brain monoamines and clinical disorders.
Progress in brain research 1982;55():419-29.
1981: K G Lloyd; Oleh Hornykiewicz; L Davidson; K Shannak; I Farley; M Goldstein; M Shibuya; W N Kelley; I H Fox
Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome.
The New England journal of medicine 1981;305(19):1106-11.
1981: G Sperk; M Berger; H Hörtnagl; Oleh Hornykiewicz
Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat.
European journal of pharmacology 1981;74(4):279-86.
1981: G Sperk; H Hörtnagl; Harald Reither; Oleh Hornykiewicz
Evidence for neuronal localization of histamine-N-methyltransferase in rat brain.
Journal of neurochemistry 1981;37(2):525-6.
1981: T Lee; Philip Seeman; Oleh Hornykiewicz; J Bilbao; J Deck; W W Tourtellotte
Parkinson's disease: low density and presynaptic location of D3 dopamine receptors.
Brain research 1981;212(2):494-8.
1981: D van der Kooy; T Hattori; K Shannak; Oleh Hornykiewicz
The pallido-subthalamic projection in rat: anatomical and biochemical studies.
Brain research 1981;204(2):253-68.
1981: M R Higatsberger; G Sperk; H Bernheimer; K S Shannak; Oleh Hornykiewicz
Striatal ganglioside levels in the rat following kainic acid lesions: comparison with Huntington's disease.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1981;44(1):93-6.
1981: G Sperk; H Hörtnagl; Harald Reither; Oleh Hornykiewicz
Changes in histamine in the rat striatum following local injection of kainic acid.
Neuroscience 1981;6(12):2669-75.
1980: G Sperk; I Galhaup; E Shlögl; H Hörtnagl; Oleh Hornykiewicz
A sensitive and reliable assay for dopamine beta-hydroxylase in tissue.
Journal of neurochemistry 1980;35(4):972-6.
1980: Oleh Hornykiewicz
[Brain dopamine and brain disorders - and what we have learned from these studies (author's transl)].
Wiener klinische Wochenschrift 1980;92(20):740-3.
1980: K G Lloyd; C H Hockmann; L Davidson; I J Farley; Oleh Hornykiewicz
Kinetics of L-DOPA metabolism in the caudate nucleus of cats with ventrotegmental lesions.
Journal of neural transmission. Supplementum 1980;(16):33-44.
1980: K S Shannak; Oleh Hornykiewicz
Brain monoamines in the rhesus monkey during long-term neuroleptic administration.
Advances in biochemical psychopharmacology 1980;24():315-23.
1980: I J Farley; K S Shannak; Oleh Hornykiewicz
Brain monoamine changes in chronic paranoid schizophrenia and their possible relation to increased dopamine receptor sensitivity.
Advances in biochemical psychopharmacology 1980;21():427-33.
1979: R G Fariello; Oleh Hornykiewicz
Substantia nigra and pentylenetetrazol threshold in rats: correlation with striatal dopamine metabolism.
Experimental neurology 1979;65(1):202-8.
1978: T Lee; Philip Seeman; Ali H Rajput; I J Farley; Oleh Hornykiewicz
Receptor basis for dopaminergic supersensitivity in Parkinson's disease.
Nature 1978;273(5657):59-61.
1978: I J Farley; K S Price; E McCullough; J H Deck; W Hordynski; Oleh Hornykiewicz
Norepinephrine in chronic paranoid schizophrenia: above-normal levels in limbic forebrain.
Science (New York, N.Y.) 1978;200(4340):456-8.
1978: M Shibuya; R Fariello; I J Farley; K S Price; K G Lloyd; Oleh Hornykiewicz
Cobalt injections into the substantia nigra of the rat: effects on behavior and dopamine metabolism in the striatum.
Experimental neurology 1978;58(3):486-99.
1978: K S Price; I J Farley; Oleh Hornykiewicz
Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine.
Advances in biochemical psychopharmacology 1978;19():293-300.
1978: K B Koffer; S Berney; Oleh Hornykiewicz
The role of the corpus striatum in neuroleptic- and narcotic-induced catalepsy.
European journal of pharmacology 1978;47(1):81-6.
1978: vladimir hachinski; M Shibuya; J W Norris; Oleh Hornykiewicz
Cerebrospinal fluid homovanillic acid in cerebral infarction.
Journal of neural transmission. Supplementum 1978;(14):45-50.
1978: Oleh Hornykiewicz
Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
Neuroscience 1978;3(9):773-83.
1977: K G Iloyd; L Shemen; Oleh Hornykiewicz
Distribution of high affinity sodium-independent [3H]gamma-aminobutyric acid [3H]GABA binding in the human brain: alterations in Parkinson's disease.
Brain research 1977;127(2):269-78.
1977: I J Farley; Oleh Hornykiewicz
Noradrenaline distribution insubcortical areas of the human brain.
Brain research 1977;126(1):53-62.
1977: I J Farley; K S Price; Oleh Hornykiewicz
Dopamine in thelimbic regions of the human brain: normal and abnormal.
Advances in biochemical psychopharmacology 1977;16():57-64.
1977: S Berney; Oleh Hornykiewicz
The effect of beta-endorphin and met-enkephalin on striatin dopamine metabolism and catalepsy: comparison with morphine.
Communications in psychopharmacology 1977;1(6):597-604.
1977: Oleh Hornykiewicz
Historical aspects and frontiers of Parkinson's disease research.
Advances in experimental medicine and biology 1977;90():1-20.
1977: K G Lloyd; M Shibuya; L Davidson; Oleh Hornykiewicz
Chronic neuroleptic therapy: tolerance and GABA systems.
Advances in biochemical psychopharmacology 1977;16():409-15.
1977: Oleh Hornykiewicz
Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
Annual review of pharmacology and toxicology 1977;17():545-59.
1976: J De Léan; J C Richardson; Oleh Hornykiewicz
Beneficial effects of serotonin precursors in postanoxic action myoclonus.
Neurology 1976;26(9):863-8.
1976: K Menon; D Bieger; Oleh Hornykiewicz
Pharmacological evidence for a selective antidopaminergic action of gamma-hydroxybutyric acid.
Journal of neural transmission 1976;39(3):177-86.
1976: Oleh Hornykiewicz
Neurohumoral interactions and basal ganglia function and dysfunction.
Research publications - Association for Research in Nervous and Mental Disease 1976;55():269-80.
1975: K G Lloyd; L Davidson; Oleh Hornykiewicz
The neurochemistry of Parkinson's disease: effect of L-dopa therapy.
The Journal of pharmacology and experimental therapeutics 1975;195(3):453-64.
1975: Oleh Hornykiewicz
Brain monoamines and parkinsonism.
National Institute on Drug Abuse research monograph series 1975;(3):13-21.
1975: R G Fariello; K G Lloyd; Oleh Hornykiewicz
Cortical and subcortical projected foci in cats: inhibitory action of taurine.
Neurology 1975;25(11):1077-83.
1975: Oleh Hornykiewicz
Brain monoamines and Parkinsonism.
Psychopharmacology bulletin 1975;11(3):34-5.
1975: Oleh Hornykiewicz
Parkinson's disease and its chemotherapy.
Biochemical pharmacology 1975;24(10):1061-5.
1975: Oleh Hornykiewicz
Parkinsonism induced by dopaminergic antagonists.
Advances in neurology 1975;9():155-64.
1974: Oleh Hornykiewicz
The mechanisms of action of L-dopa in Parkinson's disease.
Life sciences 1974;15(7):1249-59.
1974: K Kuschinsky; Oleh Hornykiewicz
Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice.
European journal of pharmacology 1974;26(1):41-50.
1974: P Derkach; L Larochelle; D Bieger; Oleh Hornykiewicz
L-DOPA-chlorpromazine antagonism on running activity in mice.
Canadian journal of physiology and pharmacology 1974;52(1):114-8.
1974: K G Lloyd; I J Farley; J H Deck; Oleh Hornykiewicz
Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients.
Advances in biochemical psychopharmacology 1974;11(0):387-97.
1974: Oleh Hornykiewicz
Some remarks concerning the possible role of brain monoamines (dopamine, noradrenaline, serotonin) in mental disorders.
Journal of psychiatric research 1974;11():249-53.
1973: H Bernheimer; W Birkmayer; Oleh Hornykiewicz; Kurt A Jellinger; F Seitelberger
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Journal of the neurological sciences 1973;20(4):415-55.
1973: J A Sharpe; N B Rewcastle; K G Lloyd; Oleh Hornykiewicz; M Hill; R R Tasker
Striatonigral degeneration. Response to levodopa therapy with pathological and neurochemical correlation.
Journal of the neurological sciences 1973;19(3):275-86.
1973: K G Lloyd; Oleh Hornykiewicz
L-glutamic acid decarboxylase in Parkinson's disease: effect of L-dopa therapy.
Nature 1973;243(5409):521-3.
1973: Oleh Hornykiewicz
Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).
British medical bulletin 1973;29(2):172-8.
1973: Oleh Hornykiewicz
Parkinson's disease: from brain homogenate to treatment.
Federation proceedings 1973;32(2):183-90.
1972: D Bieger; Oleh Hornykiewicz
Dopamine in the earthworm, Lumbricus terrestris: enhancement of rhythmic contractile activity.
Neuropharmacology 1972;11(5):745-8.
1972: K Kuschinsky; Oleh Hornykiewicz
Morphine catalepsy in the rat: relation to striatal dopamine metabolism.
European journal of pharmacology 1972;19(1):119-22.
1972: K G Lloyd; Oleh Hornykiewicz
Occurrence and distribution of aromatic L-amino acid (L-DOPA) decarboxylase in the human brain.
Journal of neurochemistry 1972;19(6):1549-59.
1972: D Bieger; L Larochelle; Oleh Hornykiewicz
A model for the quantitative study of central dopaminergic and serotoninergic activity.
European journal of pharmacology 1972;18(1):128-36.
1972: G M Brown; E Krigstein; J Dankova; Oleh Hornykiewicz
Relationship between hypothalamic and median eminence catecholamines and thyroid function.
Neuroendocrinology 1972;10(4):207-17.
1972: Oleh Hornykiewicz
Dopamine and extrapyramidal motor function and dysfunction.
Research publications - Association for Research in Nervous and Mental Disease 1972;50():390-415.
1971: C H Hockman; K G Lloyd; I J Farley; Oleh Hornykiewicz
Experimental midbrain lesions: neurochemical comparison between the animal model and Parkinson's disease.
Brain research 1971;35(2):613-8.
1971: L Davidson; K Lloyd; J Dankova; Oleh Hornykiewicz
L-DOPA treatment in Parkinson's disease: effect on dopamine and related substances in discrete brain regions.
Experientia 1971;27(9):1048-9.
1971: Oleh Hornykiewicz
Pharmacology and pathophysiology of dopaminergic neurons.
Advances in cytopharmacology 1971;1():369-77.
1971: Oleh Hornykiewicz
Neurochemical pathology and pharmacology of brain dopamine and acetylcholine: rational basis for the current drug treatment of Parkinsonism.
Contemporary neurology series 1971;8():33-65.
1970: K Lloyd; Oleh Hornykiewicz
Parkinson's disease: activity of L-dopa decarboxylase in discrete brain regions.
Science (New York, N.Y.) 1970;170(3963):1212-3.
1970: Oleh Hornykiewicz
Physiologic, biochemical, and pathological backgrounds of levodopa and possibilities for the future.
Neurology 1970;20(12):1-5.
1970: Oleh Hornykiewicz
Physiologic, biochemical, and pathological backgrounds of levodopa and possibilites for the future.
Neurology 1970;20(12):Suppl:1-5.
1970: Oleh Hornykiewicz
The metabolism of brain dopamine in human parkinsonism.
Rivista di patologia nervosa e mentale 1970;91(5):281-6.
1970: K Lloyd; Oleh Hornykiewicz
Occurrence and distribution of L-DOPA decarboxylase in the human brain.
Brain research 1970;22(3):426-8.
1968: Oleh Hornykiewicz; H J Lisch; A Springer
Homovanillic acid in different regions of the human brain: attempt at localizing central dopamine fibres.
Brain research 1968;11(3):662-71.
1968: Oleh Hornykiewicz; H Obenaus
[Acute and chronic tolerance induced by sympathoicomimetic amines].
Archives internationales de pharmacodynamie et de thérapie 1968;173(2):363-76.
1968: H J Lisch; A Aigner; Oleh Hornykiewicz
[Dopamine metabolism in the rabbit caudate nucleus following partial inhibition of brain monoamine oxidase by nialamide].
Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 1968;261(4):289-98.
1967: G S Barolin; Oleh Hornykiewicz
[On the diagnostic value of homovanillic acid in the cerebrospinal fluid].
Wiener klinische Wochenschrift 1967;79(44):815-8.
1967: A Aigner; Oleh Hornykiewicz; H J Lisch; A Springer
[The influence of diethyldithiocarbamate on cerebral catecholamine, spontaneous activity and L-DOPA hyperactivity].
Medicina et pharmacologia experimentalis. International journal of experimental medicine 1967;17(6):576-85.
1967: Oleh Hornykiewicz; H J Lisch
[Monoamine oxidase inhibitors and dopamine-(3-hydroxytyramine-) metabolism in the brain].
Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 1967;257(1):30.
1966: H Bernheimer; W Birkmayer; Oleh Hornykiewicz
[Homovanillic acid in the cerebrospinal fluid: studies in Parkinson's syndrome and other diseases of the CNS].
Wiener klinische Wochenschrift 1966;78(23):417-9.
1966: Oleh Hornykiewicz
Dopamine (3-hydroxytyramine) and brain function.
Pharmacological reviews 1966;18(2):925-64.
1966: P A van Zwieten; H Bernheimer; Oleh Hornykiewicz
[Central effect of reserpine on the circulatory reflexes of the carotid sinus].
Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 1966;253(2):310-26.
1965: H Bernheimer; Oleh Hornykiewicz
[Decreased homovanillic acid concentration in the brain in parkinsonian subjects as an expression of a disorder of central dopamine metabolism].
Klinische Wochenschrift 1965;43(13):711-5.
1964: W BIRKMAYER; Oleh Hornykiewicz
[ADDITIONAL EXPERIMENTAL STUDIES ON L-DOPA IN PARKINSON'S SYNDROME AND RESERPINE PARKINSONISM].
Archiv für Psychiatrie und Nervenkrankheiten 1964;206():367-81.
1964: Oleh Hornykiewicz
[ON THE PROBLEM OF THE DEVELOPMENT OF DOPAMINERGIC NEURONS IN THE HUMN BRAIN].
Wiener klinische Wochenschrift 1964;76():834-5.
1964: Oleh Hornykiewicz
[ON THE MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS].
Wiener klinische Wochenschrift 1964;76():289-93.
1963: Oleh Hornykiewicz
[The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease].
Wiener klinische Wochenschrift 1963;75():309-12.
1963: Oleh Hornykiewicz; G HITZENBERGER; H ZELLNER
[Experimental-pharmacological and clinical studies on a new spasmolytic "Spadon" (test name P 201-1)].
Wiener klinische Wochenschrift 1963;75():189-92 passim.
1962: Oleh Hornykiewicz
[Dopamine (3-hydroxytyramine) in the central nervous system and its relation to the Parkinson syndrome in man].
Deutsche medizinische Wochenschrift (1946) 1962;87():1807-10.
1962: H BERNHEIMER; W BIRKMAYER; Oleh Hornykiewicz
[Behavior of monoamine oxidase in the brain of man after therapy with monoamine oxidase inhibitors].
Wiener klinische Wochenschrift 1962;74():558-9.
1962: W BIRKMAYER; Oleh Hornykiewicz
[The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis].
Archiv für Psychiatrie und Nervenkrankheiten, vereinigt mit Zeitschrift für die gesamte Neurologie und Psychiatrie 1962;203():560-74.
1961: W BIRKMAYER; Oleh Hornykiewicz
[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].
Wiener klinische Wochenschrift 1961;73():787-8.
1961: H BERNHEIMER; W BIRKMAYER; Oleh Hornykiewicz
[Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].
Klinische Wochenschrift 1961;39():1056-9.
1961: H EHRINGER; Oleh Hornykiewicz; K LECHNER
[The effect of methylene blue on monoamine oxidase and the catechol amine and 5-hydroxytryptamine metabolism of the brain].
Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 1961;241():568-82.
1961: Oleh Hornykiewicz; H EHRINGER; K LECHNER
[Control of the iproniazid effect on the catecholamines and 5-hydroxytryptamine in the rat brain by chlorpromazine].
Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 1961;241():198-9.
1960: H EHRINGER; Oleh Hornykiewicz
[Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].
Klinische Wochenschrift 1960;38():1236-9.
1960: H EHRINGER; Oleh Hornykiewicz; K LECHNER
[The effect of chlorpromazine on catecholamine and 5-hydroxytryptamine metabolism in the rat brain].
Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 1960;239():507-19.
1959: F FEYRTER; G HERTTING; Oleh Hornykiewicz
[Biological effects of bronchial carcinoid extracts].
Wiener klinische Wochenschrift 1959;71(18):317-20.
1959: G HOLZER; Oleh Hornykiewicz
[On dopamine (hydroxytyramine) metabolism in the rat brain].
Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 1959;237():27-33.
1958: G V BORN; Oleh Hornykiewicz; A STAFFORD
The uptake of adrenaline and noradrenaline by blood platelets of the pig.
British journal of pharmacology and chemotherapy 1958;13(4):411-4.
1958: Oleh Hornykiewicz; H OBENAUS
[The effect of lysergic acid diethylamide on the hypotensive effects of dopamine and adrenalin].
Wiener klinische Wochenschrift 1958;70(47):948-9.
1958: Oleh Hornykiewicz
The action of dopamine on the arterial blood pressure of the guinea-pig.
British journal of pharmacology and chemotherapy 1958;13(1):91-4.
1957: G HERTTING; Oleh Hornykiewicz
[Effect of cortisone on adrenal cortex hypertrophy induced by reserpine].
Acta endocrinologica 1957;26(2):204-8.
1957: G V BORN; Oleh Hornykiewicz
The proportionality between the uptake of adrenaline by blood platelets and their content of adenosine triphosphate.
The Journal of physiology 1957;136(2):30P-1P.
1956: Oleh Hornykiewicz; I SATKE-EICHLER
[Influence of ergot alkaloids on the effect of 2,4-dinitrophenol in vitro].
Arzneimittel-Forschung 1956;6(3):117-9.
1956: Oleh Hornykiewicz; W KOBINGER
[Effects of physostigmine, tetraethylpyrophosphate, and neostigmine on the blood pressure and pressor reflexes of the carotid sinus in rats].
Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 1956;228(5):493-500.
1956: Oleh Hornykiewicz
[Demonstration of 5-hydroxytryptamine in the carcinoid of the small intestine described by Kahr].
Acta neurovegetativa 1956;13(1):110-1.
1955: Oleh Hornykiewicz
[Oxidation of adrenaline by myocardial tissue in rat in vitro].
Biochemische Zeitschrift 1955;326(4):270-9.
1954: P ELSNER; Oleh Hornykiewicz
[Effect of sex hormones of the p-polyphenoloxidase activity of the human blood serum].
Archiv für Gynäkologie 1954;185(2):251-7.
1954: H GASTAGER; Oleh Hornykiewicz; H TSCHABITSCHER
[The behavior of serum copper and p-polyphenoloxydase activity in clinical and subclinical forms of hepatolenticular diseases].
Wiener Zeitschrift für Nervenheilkunde und deren Grenzgebiete 1954;9(3):312-9.
1953: P ELSNER; Oleh Hornykiewicz; A LINDNER; G NIEBAUER
[Polyphenoloxidase activity in the maternal and fetal blood].
Wiener klinische Wochenschrift 1953;65(46):938-40.
1953: P ELSNER; Oleh Hornykiewicz; A LINDNER; G NIEBAUER
[The incidence of polyphenoloxidases in the serum of non-pregnant and pregnant women].
Wiener klinische Wochenschrift 1953;65(10):193-5.
1953: Oleh Hornykiewicz; G NIEBAUER
[Polyphenoloxidase of the human blood serum].
Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 1953;218(6):448-56.